Page 3 - Recurrent Stroke News Today

Despite being ultimately underpowered, the first randomized trial to investigate whether periodontal treatment can reduce future risk of CV events or recurrent stroke suggests some promise.

Results of a new observational study suggest the need to raise awareness among young stroke patients about the impact of chronic marijuana use, researchers say.

Interest in stenting for the treatment of symptomatic high-grade intracranial atherosclerosis may be rekindled after the results of a new trial using a drug-eluting stent.

While device closure of the PFO shows an overall benefit, a new meta-analysis suggests some may actually be harmed. Researchers have developed a scoring system to help flag those who may benefit.

In stroke patients carrying CYP2C19 loss-of-function alleles that impede metabolism of clopidogrel, ticagrelor was more effective than clopidogrel at reducing recurrent stroke in the CHANCE-2 trial.

Patients with embolic stroke of undetermined source and left ventricular dysfunction may benefit from anticoagulation to prevent a further stroke, a new analysis of the NAVIGATE ESUS trial suggested.

Admission A1c levels of 6.8% to 7.0% were linked to lower rates of future vascular events in a new study. But optimum levels may differ among stroke subtypes, data suggest.